Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St. helen (2017)
Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and abstention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St.helen (2020)
assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Stiles (2018)
Regulating food craving: From mechanisms to interventions.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Sun (2020)
Youth use of e-cigarettes: Does dependence vary by device type?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Tackett (2021)
The role of E-liquid vegetable glycerin and exhaled aerosol on cue reactivity to tank-based electronic nicotine delivery systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Vena (2019)
Exposure to JUUL use: cue reactivity effects in young adult current and former smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Vena (2020)
an Examination of Differences in acute Nicotine Withdrawal Symptoms between Electronic Nicotine Delivery System and Combustible Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Versella (2022)
On the toxicity of e-cigarettes consumption: Focus on pathological cellular mechanisms.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Vivarelli (2022)
Prevalence of and disparities in adolescents' susceptibility to novel oral nicotine products marketed as "tobacco-free".
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Vogel (2023)